lamivudine

(redirected from Epivir-HBV)
Also found in: Thesaurus, Medical.

la·miv·u·dine

 (lə-mīv′yo͞o-dēn′)
n.
An antiviral drug, C8H11N3O3S, that is a nucleoside reverse transcriptase inhibitor and is used in the treatment of chronic hepatitis B and, in combination with other drugs, in the treatment of HIV infection.

[Probably (methy)l + ami(no)- + -vudine, antiviral suff. (from zidovudine).]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lamivudine - a nucleoside reverse transcriptase inhibitor that is very effective in combination with zidovudine in treating AIDS and HIVlamivudine - a nucleoside reverse transcriptase inhibitor that is very effective in combination with zidovudine in treating AIDS and HIV
NRTI, nucleoside reverse transcriptase inhibitor - an antiviral drug used against HIV; is incorporated into the DNA of the virus and stops the building process; results in incomplete DNA that cannot create a new virus; often used in combination with other drugs
Translations

lamivudine

n lamivudina
References in periodicals archive ?
Nasdaq: MYL), a global pharmaceutical company, has launched its Lamivudine Tablets, 100 mg, the generic version of GlaxoSmithKline's Epivir-HBV, in the United States, it was reported yesterday.
In 1998, lamivudine was approved for the treatment of chronic hepatitis B infection at a dose of 100 mg once a day under the trade name Epivir-HBV (Dienstag et al.
The trial produced evidence of antiviral effectiveness, including the suppression of hepatitis B virus, and improvement in liver inflammation comparable to Epivir-HBV (lamivudine), one of five other medications approved to treat patients with chronic HBV.